Trump admin's FDA medical product review units remain protected from cuts, while Marty Makary awaits confirmation as ...
Gilead said two experimental once-a-year versions of its HIV prevention shot lenacapavir passed muster in an early-stage ...
Merck has opened a new vaccine manufacturing plant at its existing site in Durham, NC, which will make a shot that is an ...
Bristol Myers Squibb will acquire its CAR-T cell therapy collaborator 2seventy bio for $286 million in cash, the companies ...
Merck convinced a federal judge to toss claims alleging that it failed to properly warn patients of potential risks related ...
Arvinas/Pfizer's vepdegestrant shows efficacy in mutated breast cancer patients but not in broader population, failing to ...
Former Aetion CEO Carolyn Magill has joined digital health venture firm Define Ventures as a venture partner. It’s ...
Virtual physical therapy startup Hinge Health on Monday filed to go public, snapping a dry spell of digital health IPOs.
After months of reports that Walgreens was looking to go private, the retail pharmacy giant (to some folks’ surprise) managed to pull off a deal. The $10 billion transaction with Sycamore Partners, ...
Beam Therapeutics said its experimental gene editing treatment helped lower levels of mutant proteins and increase levels of ...
Mineralys Therapeutics plans $250M share offering after lorundrostat's Phase 3 success; Coherus cuts 30% staff; BioNTech's melanoma trial fails ...
Emergent BioSolutions sells Baltimore facility to Syngene International for $36.5M; site previously mixed J&J and AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback